Kijimea Irritable Bowel
Kijimea IBS is a Class IIb licensed medical device for the treatment of IBS with its typical symptoms constipation, diarrhoea, abdominal pain, flatulence and bloating. There are no known side effects or interactions with other drugs.
Take 2 capsules Kijimea IBS once a day at mealtime.
Swallow capsules whole with sufficient liquid (for example a glass of water).
We recommend taking Kijimea IBS capsules for at least four weeks, ideally for twelve weeks.
In our clinical study, the first positive effects were shown after about one week of regular intake.
Bifido-bacterial strain (B. bifidum MIMBb75 1x109 UFC/2 capsules). Maltodextrin, dextrose, hypromellose, magnesium stearate, silicon dioxide, titanium dioxide, iron oxide, brilliant blue FCF.
Kijimea IBS does not contain either preservatives, sweeteners, flavouring agents, lactose or gluten, and is also optimally suitable for patients with diabetes. Kijimea IBS does not contain gelatine either.
So far, no side effects or interactions with other products have been observed in conjunction with the use of Kijimea IBS.